The 4-dose KwikPen device supports weight reduction in patients with obesity or overweight with weight-related conditions.

Several leading Indian drugmakers have already secured regulatory approval or recommendations to produce and market generic ...

WINNIPEG, MB - March 05, 2026 - PRESSADVANTAGE - BuyCanadianInsulin.com reports that generic semaglutide may become ...

Semaglutide's patent expiry in India could sharply reduce the cost of popular weight-loss and diabetes injections.

With Ozempic and Wegovy losing protection in key markets, Indian pharma majors gear up for launches that could sharply cut prices and expand access to diabetes and weight-loss therapy The world's ...

The UK is one of the heaviest nations in Europe now with 64 per cent of the population overweight or obese, and one in four ...

AUSTIN, TX / ACCESS Newswire / March 2, 2026 / In modern metabolic medicine, few treatments have reshaped care like GLP-1 receptor agonists. If you are asking what is semaglutide, it is a prescription ...

Partner Orbicular receives ANDA approval from USFDAMUMBAI, India and WARREN, N.J., /PRNewswire/ -- Cipla USA Inc. the wholly owned ...

Abbott will exclusively distribute and market Extensior in the country, becoming the second company to secure sole distribution rights for Novo's semaglutide portfolio in India, after Emcure Pharma.

As some plus-size influencers begin taking GLP-1s, others stand firm that we should love our bodies as they are ...

KwikPen® for single-patient use available from Lilly at $449 across all doses through the Lilly Employer Connect platform, with reduced cost-share ...

Kroger’s retail rollout shifts Zepbound KwikPen distribution from direct-to-consumer to community pharmacy channels, potentially reducing friction in initiation and refills for GLP-1 obesity therapy.